Clinical Trials Directory

Trials / Unknown

UnknownNCT02600793

Ceftaroline Diffusion Into Cerebrospinal Fluid of Children

Ceftaroline Diffusion Into Cerebrospinal Fluid of Children With Ventriculitis Due to Ventriculoperitoneal Shunt (VPS) Infection

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Basim Asmar · Academic / Other
Sex
All
Age
6 Months – 17 Years
Healthy volunteers
Not accepted

Summary

Ceftaroline fosamil is an intravenous (IV) drug that belongs to a group of antibiotics called cephalosporins . Antibiotics are drugs used to treat infections. Clinical studies in adults patient shave shown ceftaroline fosamil to be effective against many bacteria that are resistant to other currently approved antibiotics. Some of these bacteria may be responsible for infections in the central nervous system.The main aim of this study is to gather information to determine how much of a single IV dose of ceftaroline fosamil will enter into a child's CSF so that the benefit of giving ceftaroline fosamil to children with infections can be better determined.

Detailed description

Children 6 months to 17 years of age admitted to the hospital because of infected VPS (ventriculitis) will be eligible for the study. A total of twelve eligible patients will be included in the study. Eligible study subjects would be patients who have undergone VPS removal and placement of EVD tubing and are being treated with standard IV antibiotics for ventriculitis. CSF cultures are obtained before antibiotics treatment is initiated. Standard initial antibiotics regimen is usually IV ceftriaxone and vancomycin. The antibiotics regimen is subsequently adjusted based on the pathogen recovered from the CSF culture. Total IV antibiotic treatment is usually 14 days. Following clearance of the infection the patient undergoes new VPS insertion by neurosurgery service.

Conditions

Interventions

TypeNameDescription
DRUGCeftarolineFollowing Ceftaroline single IV dose, 3 blood and cerbrospinal fluid samples will be collected

Timeline

Start date
2016-08-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2015-11-09
Last updated
2018-10-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02600793. Inclusion in this directory is not an endorsement.